Related Experiment Video

Updated: Jul 7, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Hemoglobin levels and coronary artery disease

Michel Chonchol1, Christopher Nielson

  • 1University of Colorado Health Sciences Center, Division of Renal Diseases and Hypertension, Denver, CO 80262, USA. michel.chonchol@uchsc.edu

American Heart Journal
|February 26, 2008
PubMed

Insights

Both low and high hemoglobin levels increase the risk of developing coronary artery disease (CAD). This study highlights the importance of monitoring hemoglobin levels for cardiovascular health.

Area of Science:

  • Cardiology
  • Hematology
  • Epidemiology

Background:

  • Anemia is a known risk factor for cardiovascular disease.
  • Limited data exists on the association between hemoglobin levels and new coronary artery disease (CAD) onset.

Purpose of the Study:

  • To investigate the relationship between baseline hemoglobin concentration and the incidence of new coronary artery disease (CAD).

Main Methods:

  • A historical cohort study of 25,622 patients from Veterans Affairs medical centers.
  • Hemoglobin levels were assessed at baseline, and CAD was identified via diagnosis codes or new nitroglycerin prescriptions.
  • Analyses were adjusted for multiple cardiovascular risk factors.

Main Results:

  • An increased risk of CAD was observed with hemoglobin levels below 15 g/dL and above 17 g/dL.
  • Compared to 15.0-17.0 g/dL, hemoglobin levels of 9.0-11.0 g/dL showed a 1.47-fold increased risk (HR 1.47, 95% CI 1.18-1.84).
  • Hemoglobin levels ≥17.0 g/dL were also associated with a 1.22-fold increased risk (HR 1.22, 95% CI 1.08-1.37).

Conclusions:

  • Both lower (<15 g/dL) and higher (≥17 g/dL) hemoglobin levels are independently associated with an increased risk of new cardiac events.
  • These findings suggest a U-shaped relationship between hemoglobin levels and CAD risk.
  • Monitoring hemoglobin levels may be crucial for assessing cardiovascular risk.
Abstract

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...